A National Academies of Sciences, Engineering, and Medicine planning committee will organize and host a 1.5-day public workshop that will examine opportunities to improve the care and outcomes for patients with cancer through public-private partnerships for clinical cancer research. The workshop will feature invited presentations and panel discussions on topics that may include:

• The potential for innovative public-private partnerships to expand and enhance clinical cancer research, including a greater emphasis on health equity.
• Strategies to further utilize the unique features of the National Cancer Clinical Trials Network (NCTN), the NCI Community Oncology Research Program (NCORP), the Experimental Therapeutics Clinical Trials Network (ETCTN), the Cancer Screening Research Network (CSRN), and other relevant networks in these partnerships.
• The unique roles of potential participants in these partnerships, including the NCTN, NCORP, ETCTN, CSRN, and the Advanced Research Projects Agency for Health (ARPA-H), FNIH and other foundations, health systems, health insurers, professional societies, disease-focused groups, and small biotech and biopharmaceutical companies.
• The patient-centered research questions or types of studies that would be most suited for public-private partnerships, such as prevention trials, adjuvant trials, comparative effectiveness trials, and pragmatic post-market trials to enable evidence generation across the lifecycle of a drug.
• Opportunities to leverage public-private collaborations to enhance the integration of cancer research within health care delivery and to utilize data that are collected during routine care to answer important questions in cancer research.
• Potential challenges to conducting efficient clinical cancer research through public-private partnerships, and potential policies and strategies to overcome those challenges.
• Characteristics and principles of effective public-private collaborations in clinical research.
• Examples of past and ongoing public-private collaborations in oncology or other biomedical fields.
• Appropriate metrics to assess the effectiveness of public-private partnerships.

The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.